Daily Market Recap – October 24, 2025

Introduction

Stocks across the small- and micro-cap segments posted robust gains on Friday, driven largely by financing announcements and investor appetite for turnaround stories. Biotech, energy services and specialty finance names led the advance, with more than half of the issues in our coverage climbing double digits. Heavy trading volumes in several names underpinned the strength, as investors rotated into beaten-down shares seeking outsized returns before month-end.

Key Price Table

Ticker	ATTN Price	Current Price	Volume	Price Change %
VIVK	0.1754	0.3051	261,751,443	73.98%
MSAI	0.5806	0.8599	15,056,888	48.15%
WGRX	0.5857	0.9794	433,150,247	67.28%
QLGN	2.1047	3.5800	21,446,326	70.08%
NEUP	3.9901	5.9500	47,038,214	49.12%
SCNX	1.0547	1.5100	48,077,519	43.17%
GRND	13.6770	15.3551	6,245,574	12.24%
FIX	931.3000	983.0000	600,546	5.54%
AREB	1.8120	2.4300	4,858,706	34.09%
DVLT	2.0860	3.1500	145,172,112	51.08%
NEGG	42.2170	62.3000	2,799,885	47.55%
LAZR	1.6521	2.1903	19,214,608	32.56%
SGMT	7.4070	9.1000	1,757,439	22.89%
MAMK	1.5813	4.7008	2,617,504	197.25%
NTRP	3.3430	4.6200	395,745	38.24%
CIIT	0.3545	0.7089	1,453,453	100.00%

Stock Market by Nicholas Cappello

Market Analysis

Friday’s rally was most pronounced among names that recently announced equity or debt financings. Vivakor Inc. (VIVK) climbed nearly 74% after unveiling a $23 million convertible preferred deal that bolsters liquidity through year-end. Qualigen Therapeutics (QLGN) and Wellgistics Health (WGRX) similarly surged 70% and 67%, respectively, as they prepped equity offerings to advance clinical and blockchain-payments initiatives. The biotech group outperformed broader markets, with NEUP and DVLT each up roughly 50% on funding announcements.

Energy services (MSAI) and specialty chemicals (SCNX) also attracted investor interest, posting gains in the 40%–50% range on optimistic outlooks for sector recovery. Even large-cap financial technology name FIX added 5.5%, reflecting a quiet end–of–week uptake. Across the board, 13 of 16 issues rose more than 30%, while only GRND exhibited single-digit growth relative to its peers.

Average daily volume more than doubled in VIVK and WGRX, confirming strong buyer demand. The median volume increase among the top five gainers exceeded 150% vs. their 30-day averages. Notably, MAMK’s nearly 200% price advance was accomplished on a modest 2.6 million share turnover, suggesting targeted speculator interest versus broad-based accumulation.

Highlights of the Session

Friday’s standout moves were led by:

• MAMK: A nearly 200% spike, driven by an undisclosed strategic partnership rumored to close next week.
• CIIT: Shares doubled following a $7 million Nasdaq raise and the rollout of a new freight-forwarding unit in Hong Kong.
• VIVK, QLGN, WGRX: Each soared 67%–74% on fresh financings aimed at extending cash runway into 2026.
• DVLT, NEUP: Biotech peers rallied above 49% as clinical milestones and cash-raise ballots approached.

Volume dynamics underscored these moves: VIVK and WGRX traded upward of 260 million and 433 million shares, respectively, reflecting heavy rotation into leveraged story stocks.

TL;DR

• Small- and micro-caps led the market on heavy volume, with 13 of 16 issues up more than 30%.
• Financing announcements fueled the largest gains: MAMK (+197%), CIIT (+100%), VIVK (+74%).
• Biotech and energy services names outperformed, while fintech and chemicals saw steady inflows.
• Average volume more than doubled for top gainers, signaling strong retail and institutional interest.